Skip to Content

2,940 Results Found

  • Article
  • Open Access
53 Citations
8,754 Views
16 Pages

Aβ is the toxic amyloid polypeptide responsible for Alzheimer’s disease (AD). Prevention and elimination of the Aβ misfolded aggregates are the promising therapeutic strategies for the AD treatments. Gammabody, the Aβ-Specific Si...

(This article belongs to the Collection Computational Antibody and Antigen Design)
  • Article
  • Open Access
11 Citations
4,370 Views
12 Pages

27 January 2021

The amyloid-β (Aβ) peptides are associated with two prominent diseases in the brain, Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA). Aβ42 is the dominant component of cored parenchymal plaques associated with AD,...

(This article belongs to the Special Issue Alzheimer’s Disease: Role and Structure of Soluble Oligomers)
  • Article
  • Open Access
5 Citations
2,228 Views
14 Pages

Correlation of Plasmatic Amyloid Beta Peptides (Aβ-40, Aβ-42) with Myocardial Injury and Inflammatory Biomarkers in Acute Coronary Syndrome

  • Luis Eduardo Del Moral,
  • Claudia Lerma,
  • Héctor González-Pacheco,
  • Alan Cristhian Chávez-Lázaro and ,
  • Felipe Massó and
  • Emma Rodriguez
  • + 1 author+ 0 author

16 February 2024

Background/Objective: Amyloid beta (β) -40 levels increase with age and inflammation states and appear to be associated with clinical manifestations of acute coronary syndrome (ACS). We investigated the correlation of Aβ peptides with myoca...

(This article belongs to the Section Cardiology)
  • Article
  • Open Access
7 Citations
2,918 Views
16 Pages

Aβ Beyond the AD Pathology: Exploring the Structural Response of Membranes Exposed to Nascent Aβ Peptide

  • Valeria Rondelli,
  • Mario Salmona,
  • Laura Colombo,
  • Giovanna Fragneto and ,
  • Giulia C. Fadda,
  • Laura Cantu’ and
  • Elena Del Favero
  • + 2 authors+ 0 author

5 November 2020

The physiological and pathological roles of nascent amyloid beta (Aβ) monomers are still debated in the literature. Their involvement in the pathological route of Alzheimer’s Disease (AD) is currently considered to be the most relevant, tr...

(This article belongs to the Special Issue Understanding Amyloid Structures and Disease: A Continuing Challenge in Health Research)
  • Article
  • Open Access
99 Citations
9,637 Views
21 Pages

Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation

  • Marcus O. W. Grimm,
  • Andrea Thiel,
  • Anna A. Lauer,
  • Jakob Winkler and ,
  • Johannes Lehmann,
  • Liesa Regner,
  • Christopher Nelke,
  • Daniel Janitschke,
  • Céline Benoist and
  • Tobias Hartmann
  • + 13 authors+ 8 authors

19 December 2017

Alzheimer’s disease (AD) is characterized by extracellular plaques in the brain, mainly consisting of amyloid-β (Aβ), as derived from sequential cleavage of the amyloid precursor protein. Epidemiological studies suggest a tight link between hypovitam...

(This article belongs to the Special Issue Vitamin D and Its Analogues: New Insights on Biological Effects and Therapeutic Uses)
  • Review
  • Open Access
9 Citations
4,568 Views
22 Pages

Understanding Aβ Peptide Binding to Lipid Membranes: A Biophysical Perspective

  • Hasna Ahyayauch,
  • Massimo E. Masserini,
  • Alicia Alonso and
  • Félix M. Goñi

Aβ peptides are known to bind neural plasma membranes in a process leading to the deposit of Aβ-enriched plaques. These extracellular structures are characteristic of Alzheimer’s disease, the major cause of late-age dementia. The mech...

(This article belongs to the Section Molecular Biophysics)
  • Feature Paper
  • Article
  • Open Access
10 Citations
4,442 Views
32 Pages

Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly

  • Nishad Thamban Chandrika,
  • Marina Y. Fosso,
  • Oleg V. Tsodikov,
  • Harry LeVine and
  • Sylvie Garneau-Tsodikova

24 December 2019

The fact that the number of people with Alzheimer’s disease is increasing, combined with the limited availability of drugs for its treatment, emphasize the need for the development of novel effective therapeutics for treating this brain disorde...

(This article belongs to the Special Issue Multifunctional Ligands Against Alzheimer's Disease)
  • Article
  • Open Access
3 Citations
4,010 Views
15 Pages

15 June 2019

Amyloid-β oligomers (AβOs) self-assemble into polymorphic species with diverse biological activities that are implicated causally to Alzheimer’s disease (AD). Synaptotoxicity of AβO species is dependent on their quaternary struct...

(This article belongs to the Special Issue Recent Advances in Self-Assembled Peptides)
  • Article
  • Open Access
36 Citations
5,187 Views
19 Pages

Design and Synthesis of Novel Hybrid 8-Hydroxy Quinoline-Indole Derivatives as Inhibitors of Aβ Self-Aggregation and Metal Chelation-Induced Aβ Aggregation

  • Suresh K. Bowroju,
  • Nirjal Mainali,
  • Srinivas Ayyadevara,
  • Narsimha R. Penthala and ,
  • Sesha Krishnamachari,
  • Samuel Kakraba,
  • Robert J. Shmookler Reis and
  • Peter A. Crooks
  • + 3 authors+ 0 author

8 August 2020

A series of novel hybrid 8-hydroxyquinoline-indole derivatives (7a–7e, 12a–12b and 18a–18h) were synthesized and screened for inhibitory activity against self-induced and metal-ion induced Aβ1–42 aggregation as potential...

(This article belongs to the Special Issue A Special Issue in Honor of Prof. Duane D. Miller)
  • Article
  • Open Access
11 Citations
3,931 Views
12 Pages

In-Depth Characterization of Endo-Lysosomal Aβ in Intact Neurons

  • Alec K. McKendell,
  • Mei C. Q. Houser,
  • Shane P. C. Mitchell,
  • Michael S. Wolfe and ,
  • Oksana Berezovska and
  • Masato Maesako
  • + 1 author+ 0 author

20 August 2022

Amyloid-beta (Aβ) peptides are produced within neurons. Some peptides are released into the brain parenchyma, while others are retained inside the neurons. However, the detection of intracellular Aβ remains a challenge since antibodies agai...

(This article belongs to the Special Issue Biosensors for Earlier Diagnosis of Alzheimer’s Disease)
  • Article
  • Open Access
25 Citations
4,597 Views
19 Pages

Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity

  • Ching-Chia Huang,
  • Kuo-Hsuan Chang,
  • Ya-Jen Chiu,
  • Yi-Ru Chen and ,
  • Tsai-Hui Lung,
  • Hsiu Mei Hsieh-Li,
  • Ming-Tsan Su,
  • Ying-Chieh Sun,
  • Chiung-Mei Chen and
  • Guey-Jen Lee-Chen
  • + 6 authors+ 1 author

9 November 2021

Alzheimer’s disease (AD) is a common neurodegenerative disease presenting with progressive memory and cognitive impairments. One of the pathogenic mechanisms of AD is attributed to the aggregation of misfolded amyloid β (Aβ), which induces neurotoxic...

(This article belongs to the Special Issue Mechanisms of Neurodevelopment and Neurodegeneration)
  • Article
  • Open Access
3 Citations
3,398 Views
24 Pages

Functional Relationships between L1CAM, LC3, ATG12, and Aβ

  • Gabriele Loers,
  • Ute Bork and
  • Melitta Schachner

9 October 2024

Abnormal protein accumulations in the brain are linked to aging and the pathogenesis of dementia of various types, including Alzheimer’s disease. These accumulations can be reduced by cell indigenous mechanisms. Among these is autophagy, whereb...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
20 Citations
8,165 Views
18 Pages

Serine Phosphorylation of IRS1 Correlates with Aβ-Unrelated Memory Deficits and Elevation in Aβ Level Prior to the Onset of Memory Decline in AD

  • Wei Wang,
  • Daisuke Tanokashira,
  • Yusuke Fukui,
  • Megumi Maruyama and ,
  • Chiemi Kuroiwa,
  • Takashi Saito,
  • Takaomi C. Saido and
  • Akiko Taguchi
  • + 3 authors+ 0 author

17 August 2019

The biological effects of insulin signaling are regulated by the phosphorylation of insulin receptor substrate 1 (IRS1) at serine (Ser) residues. In the brain, phosphorylation of IRS1 at specific Ser sites increases in patients with Alzheimer’s...

(This article belongs to the Special Issue Nutrition and Central Nervous System)
  • Review
  • Open Access
96 Citations
11,986 Views
14 Pages

Extracellular Vesicles in Alzheimer’s Disease: Friends or Foes? Focus on Aβ-Vesicle Interaction

  • Pooja Joshi,
  • Luisa Benussi,
  • Roberto Furlan,
  • Roberta Ghidoni and
  • Claudia Verderio

3 March 2015

The intercellular transfer of amyloid-β (Aβ) and tau proteins has received increasing attention in Alzheimer’s disease (AD). Among other transfer modes, Aβ and tau dissemination has been suggested to occur through release of Extracellular Vesicles (E...

(This article belongs to the Special Issue Molecular Research in Neurotoxicology)
  • Article
  • Open Access
5 Citations
2,933 Views
9 Pages

Early Animal Origin of BACE1 APP/Aβ Proteolytic Function

  • James A. Langeland,
  • Lillian Baumann,
  • Eva M. DeYoung,
  • Raphaela Angelina Varella and ,
  • Nkatha Mwenda,
  • Alejandro Aguirre and
  • D. Blaine Moore
  • + 2 authors+ 0 author

Alzheimer’s disease is characterized, in part, by the accumulation of β-amyloid (Aβ) in the brain. Aβ is produced via the proteolysis of APP by BACE1 and γ-secretase. Since BACE1 is the rate-limiting enzyme in the productio...

(This article belongs to the Section Biochemistry and Molecular Biology)
  • Perspective
  • Open Access
13 Citations
2,713 Views
65 Pages

18 December 2023

Although the long-standing Amyloid Cascade Hypothesis (ACH) has been largely discredited, its main attribute, the centrality of amyloid-beta (Aβ) in Alzheimer’s disease (AD), remains the cornerstone of any potential interpretation of the d...

(This article belongs to the Special Issue Neurodegenerative Disease: From Molecular Basis to Therapy, 2nd Edition)
  • Article
  • Open Access
3,205 Views
19 Pages

Aβ-Induced Alterations in Membrane Lipids Occur before Synaptic Loss Appears

  • Michiel Van Bulck,
  • Nicola Brandt,
  • Ralf A. Claus,
  • Markus Gräler and
  • Anja U. Bräuer

19 February 2022

Loss of active synapses and alterations in membrane lipids are crucial events in physiological aging as well as in neurodegenerative disorders. Both are related to the abnormal aggregation of amyloid-beta (Aβ) species, generally known as amyloid...

(This article belongs to the Special Issue Role of Sphingolipid Metabolism in Human Diseases)
  • Article
  • Open Access
19 Citations
4,970 Views
13 Pages

19 September 2021

The coenzyme Q10 analogue idebenone is an FDA-approved antioxidant that can cross the blood–brain barrier (BBB). The effects of idebenone on the pathology of Alzheimer’s disease (AD) and the underlying molecular mechanisms have not been comprehensive...

(This article belongs to the Special Issue Protein Folding, Aggregation, and Cell Death)
  • Communication
  • Open Access
4 Citations
3,077 Views
8 Pages

26 December 2022

The deposition of β-amyloid (Aβ) in the brain leads to neurotoxic effects and subsequent Alzheimer’s disease (AD). While AD is becoming more and more prevalent in modern society, therapeutic efforts targeting Aβ could be a promis...

(This article belongs to the Topic Nutrition in Cancer and Neurodegenerative Diseases)
  • Article
  • Open Access
7 Citations
3,260 Views
13 Pages

Background/Objectives: This study aimed to design and evaluate Chol-PEG2000 micelles and Chol-PEG500 vesicles as drug delivery system (DDS) carriers and inhibitors of amyloid-β (Aβ) aggregation, a key factor in Alzheimer’s disease (AD...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Review
  • Open Access
644 Views
17 Pages

Physiologically produced circulating β-amyloid (Aβ) exerts critical physiological functions. Although Aβ is a key player in Alzheimer’s disease (AD), it may initially be beneficial at the onset of infection. As an evolutionary co...

(This article belongs to the Special Issue Amyloid-β: An Antimicrobial Defense Peptide)
  • Article
  • Open Access
7 Citations
4,138 Views
32 Pages

Lensoside Aβ as an Adjuvant to the Anti-Glioma Potential of Sorafenib

  • Aleksandra Maciejczyk,
  • Justyna Kapral-Piotrowska,
  • Joanna Sumorek-Wiadro,
  • Adrian Zając and ,
  • Ewa Grela,
  • Rafał Luchowski,
  • Wiesław I. Gruszecki,
  • Marta Kinga Lemieszek,
  • Iwona Wertel and
  • Joanna Jakubowicz-Gil
  • + 12 authors+ 7 authors

27 May 2021

Aim: The anti-glioma effect of lensoside Aβ alone and in combination with sorafenib (pro-survival Raf kinase inhibitor) was evaluated for the first time in terms of programmed cell death induction in anaplastic astrocytoma and glioblastoma multiforme...

(This article belongs to the Special Issue Medicinal Plants and Their Active Ingredients in Cancer)
  • Perspective
  • Open Access
3 Citations
3,903 Views
136 Pages

The present Perspective analyzes the remarkable evolution of the Amyloid Cascade Hypothesis 2.0 (ACH2.0) theory of Alzheimer’s disease (AD) since its inception a few years ago, as reflected in the diminishing role of amyloid-beta (Aβ) in t...

(This article belongs to the Special Issue Traumatic Brain Injury/Chronic Traumatic Encephalopathy as Cause of Alzheimer’s Disease: Physics and Molecular Biology in the Genesis of Neurodegeneration?)
  • Article
  • Open Access
33 Citations
7,027 Views
12 Pages

Scutellarin Mitigates Aβ-Induced Neurotoxicity and Improves Behavior Impairments in AD Mice

  • Yue-Qin Zeng,
  • Yin-Bo Cui,
  • Juan-Hua Gu,
  • Chen Liang and
  • Xin-Fu Zhou

Alzheimer’s disease (AD) is pathologically characterized by excessive accumulation of amyloid-beta (Aβ) within extracellular spaces of the brain. Aggregation of Aβ has been shown to trigger oxidative stress, inflammation, and neurotoxicity resulting...

(This article belongs to the Special Issue Plant Derived Natural Products and Age Related Diseases)
  • Perspective
  • Open Access
3 Citations
3,339 Views
90 Pages

2 January 2025

A notion of the continuous production of amyloid-β (Aβ) via the proteolysis of Aβ-protein-precursor (AβPP) in Alzheimer’s disease (AD)-affected neurons constitutes both a cornerstone and an article of faith in the Alzheimer&...

(This article belongs to the Special Issue Study on Genotypes and Phenotypes of Neurodegenerative Diseases—2nd Edition)
  • Article
  • Open Access
2 Citations
2,531 Views
17 Pages

1 March 2024

The amyloidogenic Aβ peptides are widely considered as a pathogenic agent in Alzheimer’s disease. Aβ(1-42) would form aggregates of amyloid fibrils on the neuron plasma membranes, thus perturbing neuronal functionality. Conflicting da...

(This article belongs to the Collection Feature Papers in Molecular Biophysics Section)
  • Article
  • Open Access
9 Citations
5,492 Views
14 Pages

A Novel Drosophila Model of Alzheimer’s Disease to Study Aβ Proteotoxicity in the Digestive Tract

  • Greta Elovsson,
  • Therése Klingstedt,
  • Mikaela Brown,
  • K. Peter R. Nilsson and
  • Ann-Christin Brorsson

9 February 2024

Amyloid-β (Aβ) proteotoxicity is associated with Alzheimer’s disease (AD) and is caused by protein aggregation, resulting in neuronal damage in the brain. In the search for novel treatments, Drosophila melanogaster has been exten...

(This article belongs to the Special Issue Drosophila: A Versatile Model in Biology and Medicine)
  • Article
  • Open Access
41 Citations
5,951 Views
11 Pages

Exploring the Early Stages of the Amyloid Aβ(1–42) Peptide Aggregation Process: An NMR Study

  • Angelo Santoro,
  • Manuela Grimaldi,
  • Michela Buonocore,
  • Ilaria Stillitano and
  • Anna Maria D’Ursi

Alzheimer’s disease (AD) is a neurodegenerative pathology characterized by the presence of neurofibrillary tangles and amyloid plaques, the latter mainly composed of Aβ(1–40) and Aβ(1–42) peptides. The control of the Aβ aggregation process as a thera...

(This article belongs to the Special Issue High Field NMR and Ultra-High Field NMR in Medicinal Chemistry)
  • Article
  • Open Access
9 Citations
2,319 Views
17 Pages

Short-Term Inhibition of NOX2 Prevents the Development of Aβ-Induced Pathology in Mice

  • Kristina A. Mukhina,
  • Olga I. Kechko,
  • Alexander A. Osypov,
  • Irina Yu. Petrushanko and ,
  • Alexander A. Makarov,
  • Vladimir A. Mitkevich and
  • Irina Yu. Popova
  • + 2 authors+ 0 author

Alzheimer’s disease (AD) is the most common neurodegenerative disorder, characterized by the formation of neurotoxic beta-amyloid (Aβ) oligomers in the central nervous system. One of the earliest pathological effects of Aβ is the indu...

(This article belongs to the Special Issue Oxidative Stress as a Therapeutic Target of Alzheimer’s Disease)
  • Article
  • Open Access
7 Citations
3,499 Views
15 Pages

Recombinant Integrin β1 Signal Peptide Blocks Gliosis Induced by Aβ Oligomers

  • Carolina Ortiz-Sanz,
  • Francisco Llavero,
  • Jone Zuazo-Ibarra,
  • Uxue Balantzategi and ,
  • Tania Quintela-López,
  • Ane Wyssenbach,
  • Estibaliz Capetillo-Zarate,
  • Carlos Matute,
  • Elena Alberdi and
  • José L. Zugaza
  • + 5 authors+ 0 author

Glial cells participate actively in the early cognitive decline in Alzheimer’s disease (AD) pathology. In fact, recent studies have found molecular and functional abnormalities in astrocytes and microglia in both animal models and brains of pat...

(This article belongs to the Special Issue New Advances in Research on Alzheimer's Disease)
  • Article
  • Open Access
11 Citations
3,230 Views
11 Pages

Monitoring the Conformational Changes of the Aβ(25−35) Peptide in SDS Micelles: A Matter of Time

  • Angelo Santoro,
  • Michela Buonocore,
  • Manuela Grimaldi,
  • Enza Napolitano and
  • Anna Maria D’Ursi

Alzheimer’s disease is a neurodegenerative disease characterized by the formation of amyloid plaques constituted prevalently by amyloid peptides. Due to the well-known challenges related to the study in solution of these peptides, several membr...

(This article belongs to the Special Issue Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases 2.0)
  • Article
  • Open Access
46 Citations
6,392 Views
18 Pages

Polyphenols Derived from Lychee Seed Suppress Aβ (1-42)-Induced Neuroinflammation

  • Yong Tang,
  • Rui Xiong,
  • An-Guo Wu,
  • Chong-Lin Yu and ,
  • Ya Zhao,
  • Wen-Qiao Qiu,
  • Xiu-Ling Wang,
  • Jin-Feng Teng,
  • Jian Liu and
  • Da-Lian Qin
  • + 7 authors+ 2 authors

Amyloid-β (Aβ) is commonly recognized as the most important factor that results in neuronal cell death and accelerates the progression of Alzheimer’s disease (AD). Increasing evidence suggests that microglia activated by Aβ relea...

(This article belongs to the Special Issue Plant Natural Products for Human Health)
  • Article
  • Open Access
26 Citations
6,614 Views
11 Pages

Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice

  • Tian Tian,
  • Dong Bai,
  • Wen Li,
  • Guo-Wei Huang and
  • Huan Liu

9 September 2016

Alzheimer’s disease (AD) is the most common type of dementia. Amyloid-β protein (Aβ) is identified as the core protein of neuritic plaques. Aβ is generated by the sequential cleavage of the amyloid precursor protein (APP) via the APP cleaving enzyme...

  • Article
  • Open Access
5 Citations
3,783 Views
19 Pages

The Curcumin Derivative GT863 Protects Cell Membranes in Cytotoxicity by Aβ Oligomers

  • Yutaro Momma,
  • Mayumi Tsuji,
  • Tatsunori Oguchi,
  • Hideaki Ohashi and ,
  • Tetsuhito Nohara,
  • Naohito Ito,
  • Ken Yamamoto,
  • Miki Nagata,
  • Atsushi Michael Kimura and
  • Kenjiro Ono
  • + 7 authors+ 2 authors

4 February 2023

In Alzheimer’s disease (AD), accumulation of amyloid β-protein (Aβ) is one of the major mechanisms causing neuronal cell damage. Disruption of cell membranes by Aβ has been hypothesized to be the important event associated with n...

(This article belongs to the Special Issue Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases 2.0)
  • Article
  • Open Access
6 Citations
1,701 Views
14 Pages

22 May 2025

It is significant to search for ultrasensitive and accurate testing technology for point-of-care monitoring of common diseases at home; for example, monitoring the Aβ-42 level at any time is crucial for patients suffering from Alzheimer’s...

(This article belongs to the Section Sensors Development)
  • Review
  • Open Access
127 Citations
15,978 Views
33 Pages

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease

  • Md. Sahab Uddin,
  • Md. Tanvir Kabir,
  • Md. Sohanur Rahman,
  • Tapan Behl and ,
  • Philippe Jeandet,
  • Ghulam Md Ashraf,
  • Agnieszka Najda,
  • May N. Bin-Jumah,
  • Hesham R. El-Seedi and
  • Mohamed M. Abdel-Daim
  • + 5 authors+ 0 author

14 August 2020

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder related to age, characterized by the cerebral deposition of fibrils, which are made from the amyloid-β (Aβ), a peptide of 40–42 amino acids. The conversio...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
10 Citations
3,906 Views
14 Pages

Fourier Transform Infrared Spectroscopy Analysis as a Tool to Address Aβ Impact on Extracellular Vesicles

  • Margarida Vaz,
  • Tânia Soares Martins,
  • Kevin Leandro,
  • Luís Pereira de Almeida and ,
  • Odete A. B. da Cruz e Silva,
  • Alexandra Nunes and
  • Ana Gabriela Henriques
  • + 2 authors+ 0 author

10 January 2025

Alzheimer’s disease is a challenge in modern healthcare due to its complex etiology and increasing prevalence. Despite advances, further understanding of Alzheimer’s disease pathophysiology is needed, particularly the role of Aβ neur...

(This article belongs to the Section Chemical Biology)
  • Article
  • Open Access
33 Citations
4,852 Views
16 Pages

Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence

  • Francesca Pederzoli,
  • Barbara Ruozi,
  • Jason Duskey,
  • Simone Hagmeyer and ,
  • Ann Katrin Sauer,
  • Stefanie Grabrucker,
  • Romina Coelho,
  • Natalia Oddone,
  • Ilaria Ottonelli and
  • Andreas M. Grabrucker
  • + 9 authors+ 4 authors

The accumulation of amyloid β (Aβ) triggers a cascade of toxic events in Alzheimer’s disease (AD). The KLVFF peptide can interfere with Aβ aggregation. However, the peptide suffers from poor bioavailability and the inability to c...

(This article belongs to the Special Issue Drug Delivery to the Brain)
  • Article
  • Open Access
16 Citations
6,075 Views
19 Pages

Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model

  • Jasenka Rudan Njavro,
  • Marija Vukicevic,
  • Emma Fiorini,
  • Lina Dinkel and ,
  • Stephan A. Müller,
  • Anna Berghofer,
  • Chiara Bordier,
  • Stanislav Kozlov,
  • Annett Halle and
  • Sabina Tahirovic
  • + 15 authors+ 10 authors

24 December 2022

Amyloid-β (Aβ) deposition is an initiating factor in Alzheimer’s disease (AD). Microglia are the brain immune cells that surround and phagocytose Aβ plaques, but their phagocytic capacity declines in AD. This is in agreement with...

(This article belongs to the Special Issue The Role of Inflammation in Neurodegenerative Diseases and Its Therapeutic Prospects)
  • Article
  • Open Access
1 Citations
1,576 Views
16 Pages

13 June 2025

The A mating-type locus in Schizophyllum commune, which encodes homeodomain (HD) transcription factors, is essential for regulating sexual compatibility and development. While the role of the Aα sublocus and its Y-Z HD protein complex is adequa...

  • Article
  • Open Access
2 Citations
1,929 Views
14 Pages

The Alkaloid Gelsemine Reduces Aβ Peptide Toxicity by Targeting Transglutaminase Type 2 Enzyme

  • Jessica Panes-Fernández,
  • Ana M. Marileo,
  • Nicole Espinoza-Rubilar,
  • Macarena E. Meza and ,
  • Bernardita A. Salgado-Martínez,
  • Krishna Gaete-Riquelme,
  • Gustavo Moraga-Cid,
  • Patricio A. Castro,
  • Carlos F. Burgos and
  • Gonzalo E. Yévenes
  • + 6 authors+ 1 author

21 May 2025

Gelsemine, a naturally occurring indole alkaloid derived from plants of the Gelsemium species of the Gelsemiaceae family, has been extensively investigated for its neuroprotective and anti-inflammatory properties. Recent studies have demonstrated tha...

(This article belongs to the Special Issue Alkaloids: Chemical Structures with Pharmaceutical Potential)
  • Article
  • Open Access
3 Citations
2,857 Views
7 Pages

Near-Wall Aggregation of Amyloidogenic Aβ 1-40 Peptide: Direct Observation by the FRET

  • Natalia Katina,
  • Alisa Mikhaylina,
  • Nelly Ilina,
  • Irina Eliseeva and
  • Vitalii Balobanov

15 December 2021

The formation of amyloid fibrils is one of the variants of the self-organization of polypeptide chains. For the amyloid aggregation, the solution must be oversaturated with proteins. The interface of the liquid (solution) and solid (vessel walls) pha...

(This article belongs to the Special Issue Frontiers in Protein Folding and Related Areas – in Memory of Professor Sir Christopher M. Dobson (1949–2019))
  • Article
  • Open Access
8 Citations
3,687 Views
19 Pages

Neuroprotective Effects of Dehydroepiandrosterone Sulphate Against Aβ Toxicity and Accumulation in Cellular and Animal Model of Alzheimer’s Disease

  • Barbara Vuic,
  • Tina Milos,
  • Erika Kvak,
  • Marcela Konjevod and ,
  • Lucija Tudor,
  • Szidónia Farkas,
  • Gordana Nedic Erjavec,
  • Matea Nikolac Perkovic,
  • Dora Zelena and
  • Dubravka Svob Strac
  • + 5 authors+ 0 author

Background/Objectives: Beneficial effects of neurosteroid dehydroepiandrosterone sulphate (DHEAS) on cognition, emotions and behavior have been previously reported, suggesting its potential in the prevention and treatment of various neuropsychiatric...

(This article belongs to the Special Issue Molecular Research of Neurodegenerative and Psychiatric Diseases, 2nd Edition)
  • Article
  • Open Access
26 Citations
4,252 Views
15 Pages

A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated Aβ Aggregation

  • Xiaoyu Zhang,
  • Xiancheng Zhang,
  • Manli Zhong,
  • Pu Zhao and ,
  • Chuang Guo,
  • You Li,
  • He Xu,
  • Tao Wang and
  • Huiling Gao
  • + 4 authors+ 0 author

Copper (Cu) has been implicated in the progression of Alzheimer’s disease (AD), and aggregation of Cu and amyloid β peptide (Aβ) are considered key pathological features of AD. Metal chelators are considered to be potential therapeutic agents for AD...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
23 Citations
5,925 Views
16 Pages

Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme

  • Janine Mett,
  • Anna A. Lauer,
  • Daniel Janitschke,
  • Lea V. Griebsch and ,
  • Elena L. Theiss,
  • Heike S. Grimm,
  • Hennariikka Koivisto,
  • Heikki Tanila,
  • Tobias Hartmann and
  • Marcus O. W. Grimm
  • + 5 authors+ 0 author

29 October 2021

The accumulation of amyloid β-protein (Aβ) is one of the major pathological hallmarks of Alzheimer’s disease. Insulin-degrading enzyme (IDE), a zinc-metalloprotease, is a key enzyme involved in Aβ degradation, which, in addition to Aβ production, is...

(This article belongs to the Special Issue Insulin-Degrading Enzyme in Health and Disease)
  • Article
  • Open Access
41 Citations
7,374 Views
10 Pages

Salvianolic Acid B Inhibits Aβ Generation by Modulating BACE1 Activity in SH-SY5Y-APPsw Cells

  • Ying Tang,
  • Dan Huang,
  • Mei-Hua Zhang,
  • Wen-Sheng Zhang and ,
  • Yu-Xin Tang,
  • Zheng-Xiang Shi,
  • Li Deng,
  • Dai-Han Zhou and
  • Xin-Yi Lu
  • + 4 authors+ 0 author

1 June 2016

Alzheimer’s disease (AD) is a neurodegenerative disease in humans. The accumulation of amyloid-β (Aβ) plays a critical role in the pathogenesis of AD. Previous studies indicated that Salvianolic acid B (SalB) could ameliorate Aβ-induced memory impair...

  • Article
  • Open Access
25 Citations
4,431 Views
20 Pages

Green Tea Seed Oil Suppressed Aβ1–42-Induced Behavioral and Cognitive Deficit via the Aβ-Related Akt Pathway

  • Jong Min Kim,
  • Seon Kyeong Park,
  • Jin Yong Kang,
  • Su Bin Park and ,
  • Seul Ki Yoo,
  • Hye Ju Han,
  • Kyoung Hwan Cho,
  • Jong Cheol Kim and
  • Ho Jin Heo
  • + 4 authors+ 0 author

The aim of this study was to investigate the availability of seeds, one of the byproducts of green tea, and evaluate the physiological activity of seed oil. The ameliorating effect of green tea seed oil (GTO) was evaluated on H2O2-induced PC12 cells...

(This article belongs to the Section Bioactives and Nutraceuticals)
  • Article
  • Open Access
18 Citations
4,921 Views
20 Pages

Hormetic-Like Effects of L-Homocysteine on Synaptic Structure, Function, and Aβ Aggregation

  • Carla Montecinos-Oliva,
  • Macarena S. Arrázola,
  • Claudia Jara,
  • Cheril Tapia-Rojas and
  • Nibaldo C. Inestrosa

2 February 2020

Alzheimer’s Disease (AD) is the primary cause of dementia among the elderly population. Elevated plasma levels of homocysteine (HCy), an amino acid derived from methionine metabolism, are considered a risk factor and biomarker of AD and other t...

(This article belongs to the Special Issue Therapeutics Agents for Neural Repair)
  • Article
  • Open Access
13 Citations
4,852 Views
21 Pages

Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ

  • Mikael Marttinen,
  • Catarina B. Ferreira,
  • Kaisa M. A. Paldanius,
  • Mari Takalo and ,
  • Teemu Natunen,
  • Petra Mäkinen,
  • Luukas Leppänen,
  • Ville Leinonen,
  • Kenji Tanigaki and
  • Mikko Hiltunen
  • + 10 authors+ 5 authors

15 November 2020

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by aberrant amyloid-β (Aβ) and hyperphosphorylated tau aggregation. We have previously investigated the involvement of SEPTIN family members in AD-related cellular...

(This article belongs to the Section Cellular Neuroscience)
  • Article
  • Open Access
7 Citations
5,411 Views
18 Pages

Effect of Regulation of Chemerin/Chemokine-like Receptor 1/Stimulator of Interferon Genes Pathway on Astrocyte Recruitment to Aβ Plaques

  • Zhen Liu,
  • Yijun Chen,
  • Yanqing Chen,
  • Jiayi Zheng and ,
  • Wanning Wu,
  • Linlin Wang,
  • Hanqi Wang and
  • Yang Yu
  • + 3 authors+ 0 author

Recruitment and accumulation of reactive astrocytes around senile plaques are common pathological features of Alzheimer’s disease (AD), with unclear mechanisms. Chemerin, an adipokine implicated in neuroinflammation, acts through its receptor,...

(This article belongs to the Special Issue The Function of Glial Cells in the Nervous System)

of 59